Asset Details
Do you wish to reserve the book?
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma
Do you wish to request the book?
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma
2024
Overview
Clear cell renal cell carcinoma (ccRCC) is the most common form of kidney cancer, but a comprehensive description of its genomic landscape is lacking. We report the whole genome sequencing of 778 ccRCC patients enrolled in the 100,000 Genomes Project, providing for a detailed description of the somatic mutational landscape of ccRCC. We identify candidate driver genes, which as well as emphasising the major role of epigenetic regulation in ccRCC highlight additional biological pathways extending opportunities for therapeutic interventions. Genomic characterisation identified patients with divergent clinical outcome; higher number of structural copy number alterations associated with poorer prognosis, whereas VHL mutations were independently associated with a better prognosis. The observations that higher T-cell infiltration is associated with better overall survival and that genetically predicted immune evasion is not common supports the rationale for immunotherapy. These findings should inform personalised surveillance and treatment strategies for ccRCC patients.
The genomic landscape of clear cell renal cell carcinoma (ccRCC) remains to be comprehensively characterised. Here, whole genome sequencing of 778 ccRCC patients enrolled in the 100,000 Genomes Project was used to identify potential drivers and clinical correlations to inform the development of therapies.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ Aged
/ Cancer
/ Carcinoma, Renal Cell - genetics
/ Carcinoma, Renal Cell - mortality
/ Carcinoma, Renal Cell - pathology
/ Carcinoma, Renal Cell - therapy
/ Clear cell-type renal cell carcinoma
/ Female
/ Gene Expression Regulation, Neoplastic
/ Genomes
/ Genomics
/ Humanities and Social Sciences
/ Humans
/ Male
/ Mutation
/ Patients
/ Science
